Process for the synthesis of anti-neoplasia agent VNP40101M
申请人:Nanotherapeutics, Inc.
公开号:US08026395B1
公开(公告)日:2011-09-27
The present invention relates to simple, safe, high-yield methods of synthesizing VNP40101M, 1,2-bis(methylsulfonyl)-2-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine, an anti-neoplasia agent. One particularly preferred method uses methyl chloroformamide in a one-pot reaction at elevated temperatures to provide VNP40101M in high yield.